Quest Diagnostics
DGX
#1062
Rank
HK$142.11 B
Marketcap
HK$1,273
Share price
-0.18%
Change (1 day)
20.49%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Revenue for Quest Diagnostics (DGX)

Revenue in 2024 (TTM): HK$74.44 Billion

According to Quest Diagnostics 's latest financial reports the company's current revenue (TTM ) is HK$74.24 Billion. In 2023 the company made a revenue of HK$72.25 Billion a decrease over the revenue in the year 2022 that were of HK$77.21 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Quest Diagnostics from 1997 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) HK$74.44 B3.03%
2023 HK$72.25 B-6.42%
2022 HK$77.21 B-8.2%
2021 HK$84.12 B14.99%
2020 HK$73.15 B21.58%
2019 HK$60.17 B2.03%
2018 HK$58.97 B1.01%
2017 HK$58.38 B0.19%
2016 HK$58.27 B0.34%
2015 HK$58.07 B0.71%
2014 HK$57.66 B4.07%
2013 HK$55.41 B-2.02%
2012 HK$56.55 B-3.04%
2011 HK$58.33 B1.72%
2010 HK$57.34 B-0.79%
2009 HK$57.80 B3.19%
2008 HK$56.02 B7.16%
2007 HK$52.27 B7.23%
2006 HK$48.75 B14.48%
2005 HK$42.58 B6.9%
2004 HK$39.83 B8.48%
2003 HK$36.72 B14.63%
2002 HK$32.03 B13.25%
2001 HK$28.28 B6.02%
2000 HK$26.68 B55.75%
1999 HK$17.13 B51.6%
1998 HK$11.30 B-4.6%
1997 HK$11.84 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
HK$98.94 B 33.27%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.16 B-99.78%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$4.88 B-93.41%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.24 B-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.75 B-97.64%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$15.10 B-79.66%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands